Shelly F. Greenfield, MD, MPH, is an associate
professor of psychiatry at Harvard Medical School and associate
clinical director of the Alcohol and Drug Abuse Treatment Program
at McLean Hospital, where she also directs the outpatient substance
abuse treatment program and consultation services. Dr. Greenfield
is the director of the Harvard Medical School/Partners Addiction
Psychiatry Fellowship and oversees the substance abuse clinical
rotations of the adult psychiatry residency of the Massachusetts
General and McLean Hospitals. Dr. Greenfield serves as principal
investigator and co-investigator on federally funded research
focusing on treatment for substance use disorders, gender
differences in substance disorders, and health services for
substance disorders. Dr. Greenfield is past chair of the American
Psychiatric Association's Council on Addiction Psychiatry and a
member of the board of directors of the American Academy of
Addiction Psychiatry. She is chair of the National Institute on
Drug Abuse (NIDA) Clinical Trial Network's Gender Special Interest
Group and is editor-in-chief of the Harvard Review of
Psychiatry.
Cecilia M. Mikalac , MD, is a board-certified
psychiatrist who maintains a private practice in Worcester,
Massachusetts, specializing in adult psychiatry. Her expertise
includes insightoriented and cognitive-behavioral psychotherapy,
character pathology, obsessive-compulsive disorder,
neuropsychiatry, and physician patients. Dr. Mikalac received her
medical degree from Temple University Medical School and completed
her residency and psychotherapy fellowship at University of
Massachusetts Medical Center in Worcester. Dr. Mikalac is active in
the Massachusetts Medical Society, currently serving as president
of the Middlesex West District Medical Society, vice chair of the
Committee on Women in Medicine, a delegate to the MMS House of
Delegates, and on several other committees and task forces. She is
the author of Money and Outpatient Psychiatry: Practice Guidelines
From Accounting to Ethics, as well as the online course Money and
Ethics for Mental Health Professionals.
Sonya S. Shin , MD, MPH, received her medical
degree in 1998 from Harvard Medical School and her master's in
public health from Harvard School of Public Health in 2004. She is
an assistant professor of medicine at Harvard Medical School and an
associate physician in the Division of Infectious Diseases and the
Division of Global Health Equity at Brigham and Women's Hospital.
Dr. Shin trained in infectious diseases and provides HIV and TB
care in Boston, Peru, and Russia. Her research projects include a
randomized trial to treat alcohol disorders among TB patients in
Russia, an operational study to assess the clinical and
costeffectiveness impact of rapid-drug susceptibility testing when
implemented in Peru under program conditions, and a
clusterrandomized trial to provide community-based accompaniment
with supervised antiretroviral therapy to impoverished HIV patients
in Peru. Dr. Shin is also leading a project to provide
community-based care for individuals with poorly controlled chronic
diseases in the Navajo Nation.
Hilary Smith Connery, MD, PhD, a
board-certified psychiatrist is the medical director of residential
and ambulatory services in the Division of Alcohol and Drug Abuse
at McLean Hospital. She also designed and directs the outpatient
buprenorphine stabilization program for patients with opioid
dependence and co-occurring psychiatric illness and received a
Harvard Medical Scholars Research Award to study treatment outcomes
in this population. She is currently a principal investigator for
the Harvard University Northern New England Node of the National
Institute on Drug Abuse (NIDA) Clinical Trials Network (CTN), part
of a national multisite clinical trial studying outcomes of
buprenorphine treatment and counseling for patients with
prescription opioid dependence. Dr. Connery is an author of the
American Psychiatric Association Practice Guidelines for treatment
of patients with substance use disorders and a recognized member of
Best Doctors in America. She maintains a discreet private practice
with adult consultation services and treatment.
Lu Wang , MD, PhD, received her medical degree
from Peking University in 1997 and her doctoral degree from the
University of Minnesota in 2004. From 2005 to 2007, she was a
postdoctoral fellow in the Department of Medicine in the Division
of Preventive Medicine at Brigham and Women's Hospital. She joined
the faculty in the division in 2007. Dr. Wang's primary research
interest focuses on the development and prevention of
cardiovascular disease and related health conditions. Since 2000,
Dr. Wang has been working on several large population-based
epidemiologic studies to investigate the lifestyle risk factors,
biomarkers, genetic markers, and subclinical measurements for
hypertension, diabetes, and cardiovascular disease. She is the
primary author of several recently published studies on diet and
hypertension.
